182 related articles for article (PubMed ID: 34555232)
1. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
Chen P; Lu W; Chen T
J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
3. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
4. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
Mu Y; Li J; Xie F; Xu L; Xu G
J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
[TBL] [Abstract][Full Text] [Related]
5. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
6. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
[TBL] [Abstract][Full Text] [Related]
8. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
Li W; Sun Y; Xu N
Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
Mu Y; Xie F; Sun T
J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic efficiency of seven autoantibodies in lung cancer.
Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
[TBL] [Abstract][Full Text] [Related]
11. Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array.
Jiang D; Zhang X; Liu M; Wang Y; Wang T; Pei L; Wang P; Ye H; Shi J; Song C; Wang K; Wang X; Dai L; Zhang J
Front Immunol; 2021; 12():658922. PubMed ID: 33968062
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
[TBL] [Abstract][Full Text] [Related]
13. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
[TBL] [Abstract][Full Text] [Related]
14. The role of seven autoantibodies in lung cancer diagnosis.
Luo B; Mao G; Ma H; Chen S
J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
[TBL] [Abstract][Full Text] [Related]
15. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer.
Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X
J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153
[TBL] [Abstract][Full Text] [Related]
16. The role of autoantibody detection in the diagnosis and staging of lung cancer.
Wang Y; Jiao Y; Ding CM; Sun WZ
Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182
[TBL] [Abstract][Full Text] [Related]
17. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
[TBL] [Abstract][Full Text] [Related]
18. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Seven Autoantibodies Combined with CEA and CA199 in Non-Small Cell Lung Cancer.
Xie F; Xu L; Mu Y; Zhang R; Li J; Xu G
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145062
[TBL] [Abstract][Full Text] [Related]
20. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]